Healthy Volunteers
"Healthy Volunteers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Persons with no known significant health problems who are recruited to participate in research to test a new drug, device, or intervention as controls for a patient group. (from http://clinicalcenter.nih.gov/recruit/volunteers.html, accessed 2/14/2013)
Descriptor ID |
D064368
|
MeSH Number(s) |
M01.774.500 M01.955.236
|
Concept/Terms |
Healthy Volunteers- Healthy Volunteers
- Healthy Volunteer
- Volunteer, Healthy
- Healthy Participants
- Healthy Participant
- Participant, Healthy
- Participants, Healthy
- Healthy Subjects
- Healthy Subject
- Subject, Healthy
- Subjects, Healthy
Human Volunteers- Human Volunteers
- Human Volunteer
- Volunteer, Human
- Volunteers, Human
Normal Volunteers- Normal Volunteers
- Normal Volunteer
- Volunteer, Normal
- Volunteers, Normal
|
Below are MeSH descriptors whose meaning is more general than "Healthy Volunteers".
Below are MeSH descriptors whose meaning is more specific than "Healthy Volunteers".
This graph shows the total number of publications written about "Healthy Volunteers" by people in this website by year, and whether "Healthy Volunteers" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 0 | 1 | 1 | 2014 | 0 | 1 | 1 | 2015 | 0 | 1 | 1 | 2017 | 0 | 1 | 1 | 2019 | 0 | 1 | 1 | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Healthy Volunteers" by people in Profiles.
-
Mutawi TM, Zedan MM, Yahya RS, Zakria MM, El-Sawi MR, Gaedigk A. Genetic variability of CYP2D6, CYP3A4 and CYP3A5 among the Egyptian population. Pharmacogenomics. 2021 04; 22(6):323-334.
-
Stancil SL, Pearce RE, Tyndale RF, Kearns GL, Vyhlidal CA, Leeder JS, Abdel-Rahman S. Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults. Br J Clin Pharmacol. 2019 05; 85(5):960-969.
-
Burgess KS, Ipe J, Swart M, Metzger IF, Lu J, Gufford BT, Thong N, Desta Z, Gaedigk R, Pearce RE, Gaedigk A, Liu Y, Skaar TC. Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAs. Clin Pharmacol Ther. 2018 07; 104(1):130-138.
-
Dodgen TM, Labuschagne CJ, van Schalkwyk A, Steffens FE, Gaedigk A, Cromarty AD, Alessandrini M, Pepper MS. Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort. Pharmacogenomics J. 2016 11; 16(6):566-572.
-
Tay-Sontheimer J, Shireman LM, Beyer RP, Senn T, Witten D, Pearce RE, Gaedigk A, Gana Fomban CL, Lutz JD, Isoherranen N, Thummel KE, Fiehn O, Leeder JS, Lin YS. Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics. Pharmacogenomics. 2014 Dec; 15(16):1947-62.
-
Herrmann SD, Martin LE, Breslin FJ, Honas JJ, Willis EA, Lepping RJ, Gibson CA, Befort CA, Lambourne K, Burns JM, Smith BK, Sullivan DK, Washburn RA, Yeh HW, Donnelly JE, Savage CR. Neuroimaging studies of factors related to exercise: rationale and design of a 9 month trial. Contemp Clin Trials. 2014 Jan; 37(1):58-68.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|